Showing results (1231-1240 of 1,523) with videos related to
Sort By:
Pageof 153
Frontiers in Molecular Biosciences|August 5, 2022
Effects of PCSK9 inhibitors on HDL cholesterol efflux and serum cholesterol loading capacity in familial hypercholesterolemia subjects: a multi-lipid-center real-world evaluationMarcella Palumbo, Antonina Giammanco, Francesco Purrello, et al.Journal for Immunotherapy of Cancer|September 4, 2021
Intratumoral injection of TLR9 agonist promotes an immunopermissive microenvironment transition and causes cooperative antitumor activity in combination with anti-PD1 in pancreatic cancerCarmine Carbone, Geny Piro, Antonio Agostini, et al.Journal of Neuropathology and Experimental Neurology|August 10, 2017
Molecular Transition of an Adult Low-Grade Brain Tumor to an Atypical Teratoid/Rhabdoid Tumor Over a Time-Course of 14 YearsYvonne Schweizer, Zsolt Meszaros, David T W Jones, et al.Oncoimmunology|September 22, 2017
A circulating T<sub>H</sub>2 cytokines profile predicts survival in patients with resectable pancreatic adenocarcinomaGeny Piro, Francesca Simionato, Carmine Carbone, et al.Journal of Clinical Medicine|January 21, 2023
The Feasibility, Effectiveness and Acceptance of Virtual Visits as Compared to In-Person Visits among Clinical Electrophysiology Patients during the COVID-19 PandemicMarco Valerio Mariani, Nicola Pierucci, Giovanni Battista Forleo, et al.Journal of Clinical Lipidology|March 1, 2020
Arterial stiffness improvement after adding on PCSK9 inhibitors or ezetimibe to high-intensity statins in patients with familial hypercholesterolemia: A Two-Lipid Center Real-World ExperienceGiuseppe Mandraffino, Roberto Scicali, Javier Rodríguez-Carrio, et al.Cardiovascular Diabetology|May 21, 2025
Cardiovascular risk profile in subjects with diabetes: Is SCORE2-Diabetes reliable?Sabrina Scilletta, Maurizio Di Marco, Nicoletta Miano, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2019
Adaptive Resistance to Dual BRAF/MEK Inhibition in BRAF-Driven Tumors through Autocrine FGFR Pathway ActivationVictoria E Wang, Jenny Y Xue, Dennie T Frederick, et al.Alzheimer'S & Dementia (Amsterdam, Netherlands)|April 7, 2022
Role of tau deposition in early cognitive decline in Down syndromeSigan L Hartley, Benjamin L Handen, Dana Tudorascu, et al.Discover Oncology|February 24, 2022
Involvement of transcribed lncRNA uc.291 and SWI/SNF complex in cutaneous squamous cell carcinomaM Mancini, A Cappello, R Pecorari, et al.Pageof 153